Mayo Clinic January 17, 2022
A better understanding of proteomics, genomics, and a variety of other biomarkers can help personalize patient care and shed new light on human physiology and pathology.
By John Halamka, M.D., president, Mayo Clinic Platform, and Paul Cerrato, senior research analyst and communications specialist, Mayo Clinic Platform
Some have called the human body a kind of “Black box”. There is much we don’t understand about human physiology and pathology. Despite centuries of laboratory experimentation and clinical trials, it is not yet the standard of care to integrate multi-modal data – phenotype, genotype, imaging, digital pathology, and telemetry to provide personalized diagnosis and treatment.
Fortunately, tools are evolving that include a long list of omics like genomics, proteomics, metabolomics, and microbiomics....
Today's Sponsors
Today's Sponsor